SAMAR ABDEL-JABBAR: Open Payments
NPI 1942656012 · LONGWOOD, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$348 in 22 payments from 8 companies in 2025. Trend: 2023 $229 · 2024 $513 · 2025 $348
Food & beverage: $348
| Company | Payments | Amount |
|---|---|---|
| Supernus Pharmaceuticals, Inc. | 11 | $128 |
| Collegium Pharmaceutical, Inc. | 3 | $52 |
| Tris Pharma Inc | 2 | $44 |
| ALK-Abello, Inc | 2 | $37 |
| Corium, LLC | 1 | $33 |
| Merck Sharp & Dohme LLC | 1 | $23 |
| Cranial Technologies, Inc | 1 | $17 |
| Kowa Pharmaceuticals America, Inc. | 1 | $14 |
Products named: Qelbree, Jornay PM, Dyanavel XR, NEFFY, Azstarys, ROTATEQ, Doc Band, ZORYVE.
Industry payments across FL — which companies pay providers there.
